Frontiers in Endocrinology (Jul 2022)

An Elevated METS-IR Index Is Associated With Higher Asthma Morbidity and Earlier Age of First Asthma in US Adults: Results Based on a Cross-Sectional Study

  • Yan Chen,
  • Junping Yang,
  • Kexing Han,
  • Yan Wang,
  • Cuixia Zhuang,
  • Laxiang Zhu,
  • Mingwei Chen

DOI
https://doi.org/10.3389/fendo.2022.920322
Journal volume & issue
Vol. 13

Abstract

Read online

ObjectiveThe purpose of this study was to evaluate whether there is a correlation between the METS-IR index and asthma among Americans.MethodsIn an attempt to establish the relationship between the METS-IR index and asthma prevalence and age at first onset of asthma, we conducted a logistic regression analysis, subgroup analysis, and dose-response curve analysis using the National Health and Nutrition Examination Survey (NHANES) database.ResultsIn model 3, each unit increase in METS-IR index led to 1.5% increase in asthma prevalence (OR= 1.015, 95% CI: 1.012, 1.018) and an earlier age of onset of asthma by 0.057years (β= -0.057, 95% CI: -0.112, -0.002).Stratified analysis determined that an increase in METS-IR index was associated with asthma prevalence in almost all subgroups, except in the group where it was not known whether a blood relative had asthma, and a positive linear relationship was found between METS-IR index and asthma prevalence, as well as a linear negative relationship with age at asthma onset.ConclusionDespite the fact that a direct causal relationship cannot be demonstrated, a higher METS-IR index is positively related to asthma prevalence and correspondingly may result in asthma onset at younger ages.

Keywords